相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study
Ahmet Gul et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Role of ST2 in Non-ST-Elevation Acute Coronary Syndrome in the MERLIN-TIMI 36 Trial
Payal Kohli et al.
CLINICAL CHEMISTRY (2012)
Risk stratification of ischaemic patients with implantable cardioverter defibrillators by C-reactive protein and a multi-markers strategy: results of the CAMI-GUIDE study
Luigi M. Biasucci et al.
EUROPEAN HEART JOURNAL (2012)
Right ventricular systolic dysfunction in patients with reperfused ST-segment elevation acute myocardial infarction
Benjamin W. Van Tassell et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice
Matthew R. Alexander et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure
Benjamin W. Van Tassell et al.
PLOS ONE (2012)
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
Paul M. Ridker et al.
AMERICAN HEART JOURNAL (2011)
Challenges and Opportunities for Cardiovascular Disease Prevention
Manuel Franco et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
Naomi Schlesinger et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice
Vinay Bhaskar et al.
ATHEROSCLEROSIS (2011)
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Charles A. Dinarello
BLOOD (2011)
Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study
Rieke Alten et al.
BMC MUSCULOSKELETAL DISORDERS (2011)
Heart Disease and Stroke Statistics-2011 Update A Report From the American Heart Association
Veronique L. Roger et al.
CIRCULATION (2011)
Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of Care
Jeffrey R. Curtis et al.
CLINICAL THERAPEUTICS (2011)
INVESTIGATION OF IL-1 INHIBITION IN PATIENTS PRESENTING WITH NON-ST ELEVATION MYOCARDIAL INFARCTION ACUTE CORONARY SYNDROMES (THE MRC ILA HEART STUDY)
A. C. Morton et al.
HEART (2011)
Blocking interleukin-1 beta in acute and chronic autoinflammatory diseases
C. A. Dinarello
JOURNAL OF INTERNAL MEDICINE (2011)
High-Sensitivity C-Reactive Protein Is Within Normal Levels at the Very Onset of First ST-Segment Elevation Acute Myocardial Infarction in 41% of Cases A Multiethnic Case-Control Study
Nicole Cristell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Alterations in the Interleukin-1/Interleukin-1 Receptor Antagonist Balance Modulate Cardiac Remodeling following Myocardial Infarction in the Mouse
Antonio Abbate et al.
PLOS ONE (2011)
The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
Eleonora Mezzaroma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Association of soluble apoptotic markers with impaired left ventricular deformation in patients with rheumatoid arthritis. Effects of inhibition of interleukin-1 activity by anakinra
Ignatios Ikonomidis et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Type 2 diabetes as an inflammatory disease
Marc Y. Donath et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)
Antonio Abbate et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Canakinumab for the Treatment of Acute Flares in Difficult-to-Treat Gouty Arthritis Results of a Multicenter, Phase II, Dose-Ranging Study
Alexander So et al.
ARTHRITIS AND RHEUMATISM (2010)
Prognostic value of cytokines and chemokines in addition to the GRACE Score in non-ST-elevation acute coronary syndromes
Luis C. L. Correia et al.
CLINICA CHIMICA ACTA (2010)
XOMA 052, an Anti-IL-1β Monoclonal Antibody, Improves Glucose Control and β-Cell Function in the Diet-Induced Obesity Mouse Model
Alexander M. Owyang et al.
ENDOCRINOLOGY (2010)
Interleukin-1β modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse
Antonio Abbate et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Kinetic Approach to Pathway Attenuation Using XOMA 052, a Regulatory Therapeutic Antibody That Modulates Interleukin-1β Activity
Marina K. Roell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Pharmacologic Inhibition of Myeloid Differentiation Factor 88 (MyD88) Prevents Left Ventricular Dilation and Hypertrophy After Experimental Acute Myocardial Infarction in the Mouse
Benjamin W. Van Tassell et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Interleukin-1 Trap Attenuates Cardiac Remodeling After Experimental Acute Myocardial Infarction in Mice
Benjamin W. Van Tassell et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Efficacy and Safety of Immediate Angioplasty Versus Ischemia-Guided Management After Thrombolysis in Acute Myocardial Infarction in Areas With Very Long Transfer Distances Results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-Elevation Myocardial Infarction)
Ellen Bohmer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Stephen Kaptoge et al.
LANCET (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
Kristiina Rajamaki et al.
PLOS ONE (2010)
Rilonacept-CAPS and Beyond A Scientific Journey
Neil Stahl et al.
CYTOKINE THERAPIES: NOVEL APPROACHES FOR CLINICAL INDICATIONS (2009)
The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
R. Terkeltaub et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis
I. Ikonomidis et al.
HEART (2009)
Inflammasomes: too big to miss
Andrea Stutz et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
Paul M. Ridker
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Primary and Secondary Prevention of Cardiovascular Diseases: A Practical Evidence-Based Approach
James H. O'Keefe et al.
MAYO CLINIC PROCEEDINGS (2009)
Interleukin-1 Regulates Multiple Atherogenic Mechanisms in Response to Fat Feeding
Janet Chamberlain et al.
PLOS ONE (2009)
Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease - A randomized placebo-controlled study
Juliano Lara Fernandes et al.
ATHEROSCLEROSIS (2008)
Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis
Ignatios Ikonomidis et al.
CIRCULATION (2008)
Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction
Antonio Abbate et al.
CIRCULATION (2008)
Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction
Raghava S. Velagaleti et al.
CIRCULATION (2008)
Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation
A. Abbate et al.
HEART (2008)
Tumour necrosis factor antagonists: structure, function, and tuberculosis risks
Robert S. Walls
LANCET INFECTIOUS DISEASES (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Investigation of the effect of Interleukin-1 receptor antagonist (IL-Ira) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study)
David C. Crossman et al.
TRIALS (2008)
The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation
T. Fernandes-Alnemri et al.
CELL DEATH AND DIFFERENTIATION (2007)
Recurrent angina after coronary revascularization: a clinical challenge
Antonio Abbate et al.
EUROPEAN HEART JOURNAL (2007)
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Claus M. Larsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome
T. Kilic et al.
HEART (2006)
Safety of extended treatment with anakinra in patients with rheumatoid arthritis
R. M. Fleischmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Interleukin-1β and signaling of interleukin-1 in vascular wail and circulating cells modulates the extent of neointima formation in mice
J Chamberlain et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients
HCA Emsley et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Increased circulating C-reactive protein and macrophage-colony stimulating factor are complementary predictors of long-term outcome in patients with chronic coronary artery disease
I Ikonomidis et al.
EUROPEAN HEART JOURNAL (2005)
Targeted anticytokine therapy and the failing heart
DL Mann
AMERICAN JOURNAL OF CARDIOLOGY (2005)
C-reactive protein levels and outcomes after statin therapy
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Targeted anticytokine therapy in patients with chronic heart failure - Results of the Randomized Etanercept Worldwide evALuation (RENEWAL)
DL Mann et al.
CIRCULATION (2004)
Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial
DL Brown et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein - A randomized placebo-controlled study
P Bogaty et al.
CIRCULATION (2004)
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease - Application to Clinical and Public Health Practice - Clinical use of inflammatory markers in patients with cardiovascular diseases - A background paper
LM Biasucci
CIRCULATION (2004)
Widespread myocardial inflammation and infarct-related artery patency
A Abbate et al.
CIRCULATION (2004)
Anakinra: Review of recombinant human interieukin-1 receptor antagonist in the treatment of rheumatoid arthritis
DE Furst
CLINICAL THERAPEUTICS (2004)
Terminology for high-risk and vulnerable coronary artery plaques - Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece
JA Schaar et al.
EUROPEAN HEART JOURNAL (2004)
Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice
K Isoda et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
ES Chung et al.
CIRCULATION (2003)
Meta-analysis of corticosteroid treatment in acute myocardial infarction
GR Giugliano et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Is there a vulnerable plaque?
A Maseri et al.
CIRCULATION (2003)
Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis - A large, international, multicenter, placebo-controlled trial
RM Fleischmann et al.
ARTHRITIS AND RHEUMATISM (2003)
Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study)
F Versaci et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation - The nonsteroidal anti-inflammatory drugs in unstable angina treatment-2 (NUT-2) pilot study
R Altman et al.
CIRCULATION (2002)
Inflammation and atherosclerosis
P Libby et al.
CIRCULATION (2002)
Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention
G Patti et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Risk of cardiovascular events associated with selective COX-2 inhibitors
D Mukherjee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis
R Dewberry et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Clinical significance of increased plasma concentration of macrophage colony-stimulating factor in patients with angina pectoris
T Saitoh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
分享论文
